Development of gastric tumors in ApcMin/+ mice by the activation of the β-catenin/Tcf signaling pathway

Cancer Research

Volumn 67, Issue 9, 2007, Pages 4079-4087

  Tomita, Hiroyuki ^a   Yamada, Yasuhiro ^a   Oyama, Takeru ^a   Hata, Kazuya ^a   Hirose, Yoshinobu ^a   Hara, Akira ^a   Kunisada, Takahiro ^a   Sugiyama, Yasuyuki ^a   Adachi, Yosuke ^a   Linhart, Heinz ^b   Mori, Hideki ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; APC; BETA CATENIN; CYCLIN D1; METHYLNITROSOUREA; T CELL FACTOR PROTEIN;

ADENOMATOUS POLYP; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ANIMALS; BETA CATENIN; CELL NUCLEUS; FEMALE; GENE EXPRESSION; GENES, APC; LOSS OF HETEROZYGOSITY; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM INVASIVENESS; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; T CELL TRANSCRIPTION FACTOR 1; TRANSCRIPTION, GENETIC;

EID: 34249317261     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-4025     Document Type: Article

References (50)

1. Nishisho I, Nakamura Y, Miyoshi Y, et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991;253:665-9.
2. Kinzler KW, Nilbert MC, Su LK, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253:661-5.
3. Kinzler KW, Vogelstein B. Lessons from hereditary colorectal cancer. Cell 1996;87:159-70.
4. Korinek V, Barker N, Morin PJ, et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma. Science 1997;275:1784-7.
5. Morin PJ, Sparks AB, Korinek V, et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997;275:1787-90.
6. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14:1837-51.
7. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003;1653:1-24.
8. Rubinfeld B, Robbins P, El-Gamil M, Albert I, Porfiri E, Polakis P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 1997;275:1790-2.
9. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998;281: 1509-12.
10. Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398:422-6.
11. Hamilton JP, Meltzer SJ. A review of the genomics of gastric cancer. Clin Gastroenterol Hepatol 2006;4:416-25.
12. Oshima H, Matsunaga A, Fujimura T, Tsukamoto T, Taketo MM, Oshima M. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 2006;131:1086-95.
13. Clements WM, Wang J, Sarnaik A, et al. β-Catenin mutation is a frequent cause of Wnt pathway activation in gastric cancer. Cancer Res 2002;62:3503-6.
14. Woo DK, Kim HS, Lee HS, Kang YH, Yang HK, Kim WH. Altered expression and mutation of β-catenin gene in gastric carcinomas and cell lines. Int J Cancer 2001;95:108-13.
15. Ushijima T, Sasako M. Focus on gastric cancer. Cancer Cell 2004;5:121-5.
16. Lee JH, Abraham SC, Kim HS, et al. Inverse relationship between APC gene mutation in gastric-adenomas and development of adenocarcinoma. Am J Pathol 2002;161:611-8.
17. Ebert MP, Fei G, Kallmann S, et al. Increased β-catenin mRNA levels and mutational alterations of the APC and β-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 2002;23:87-91.
18. Horii A, Nakatsuru S, Miyoshi Y, et al. The APC gene, responsible for familial adenomatous polyposis, is mutated in human gastric cancer. Cancer Res 1992; 52:3231-3.
19. Jagelman DG, DeCosse JJ, Bussey HJ. Upper gastrointestinal cancer in familial adenomatous polyposis. Lancet 1988;1:1149-51.
20. Offerhaus GJ, Giardiello FM, Krush AJ, et al. The risk of upper gastrointestinal cancer in familial adenomatous polyposis. Gastroenterology 1992;102:1980-2.
21. Iwama T, Mishima Y, Utsunomiya J. The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment. Ann Surg 1993;217:101-8.
22. Nugent KP, Spigelman AD, Phillips RK. Risk of cxtracolonic cancer in familial adenomatous polyposis. Br J Surg 1996;83:1121-2.
23. Moser AR, Pitot HC, Dove WF. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse. Science 1990;247:322-4.
24. Luongo C, Moser AR, Gledhill S, Dove WF. Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 1994;54:5947-52.
25. Oshima M, Oshima H, Kitagawa K, Kobayashi M, Itakura C, Taketo M. Loss of Apc heterozygosity and abnormal tissue building in nascent intestinal polyps in mice carrying a truncated Apc gene. Proc Natl Acad Sci U S A 1995;92:4482-6.
26. Fox JG, Dangler CA, Whary MT, Edelman W, Kucherlapati R, Wang TC. Mice carrying a truncated Apc gene have diminished gastric epithelial proliferation, gastric inflammation, and humoral immunity in response to Helicobacter felis infection. Cancer Res 1997;57:3972-8.
27. Yang K, Edelmann W, Fan K, et al. A mouse model of human familial adenomatous polyposis. J Exp Zool 1997;277:245-54.
28. Perreault N, Sackett SD, Katz JP, Furth EE, Kaestner KH. Fox11 is a mesenchymal modifier of Min in carcinogenesis of stomach and colon. Genes Dev 2005;19:311-5.
29. Mutoh H, Sakurai S, Satoh K, et al. Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res 2004;64:7740-7.
30. Cooper HS, Chang WC, Coudry R, et al. Generation of a unique strain of multiple intestinal neoplasia (Apc(+/Min-FCCC)) mice with significantly increased numbers of colorectal adenomas. Mol Carcinog 2005; 44:31-41.
31. Colnot S, Niwa-Kawakita M, Hamard G, et al. Colorectal cancers in a new mouse model of familial adenomatous polyposis: influence of genetic and environmental modifiers. Lab Invest 2004;84: 1619-30.
32. Ritland SR, Gendler SJ. Chemoprevention of intestinal adenomas in the ApcMin mouse by piroxicam: kinetics, strain effects and resistance to chemosuppression. Carcinogenesis 1999;20:51-8.
33. Wasan HS, Novelli M, Bee J, Bodmer WF. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. Proc Natl Acad Sci U S A 1997;94:3308-13.
34. Yamachika T, Nakanishi H, Inada K, et al. N-methyl-N- nitrosourea concentration-dependent, rather than total intake-dependent, induction of adenocarcinomas in the glandular stomach of BALB/c mice. Jpn J Cancer Res 1998;89:385-91.
35. Lu J, Imamura K, Nomura S, et al. Chemopreventive effect of peroxisome proliferator-activated receptor γ on gastric carcinogenesis in mice. Cancer Res 2005;65: 4769-74.
36. Boivin GP, Washington K, Yang K, et al. Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 2003;124: 762-77.
37. Nam KT, Hahm KB, Oh SY, et al. The selective cyclooxygenase-2 inhibitor nimesulide prevents Helicobacter pylori-associated gastric cancer development in a mouse model. Clin Cancer Res 2004;10:8105-13.
38. Yamada Y, Hata K, Hirose Y, et al. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice. Cancer Res 2002; 62:6367-70.
39. Yamada Y, Jackson-Grusby L, Linhart H, et al. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci U S A 2005;102:13580-5.
40. Merchant JL. Inflammation, atrophy, gastric cancer: connecting the molecular dots. Gastroenterology 2005; 129:1079-82.
41. Stock M, Otto F. Gene deregulation in gastric cancer. Gene 2005;360:1-19.
42. Su LK, Kinzler KW, Vogelstein B, et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992;256: 668-70.
43. Yuasa Y. Control of gut differentiation and intestinal-type gastric carcinogenesis. Nat Rev Cancer 2003;3:592-600.
44. Yamamoto M, Tsukamoto T, Sakai H, et al. p53 knockout mice (-/-) are more susceptible than (+/-) or (+/+) mice to N-methyl-N-nitrosourea stomach carcinogenesis. Carcinogenesis 2000;21:1891-7.
45. Nakamura Y, Sakagami T, Yamamoto N, et al. Helicobacter pylori does not promote N-methyl-N-nitrosourea-induced gastric carcinogenesis in SPF C57BL/6 mice. Jpn J Cancer Res 2002;93:111-6.
46. Han SU, Kim YB, Joo HJ, et al. Helicobacter pylori infection promotes gastric carcinogenesis in a mice model. J Gastroenterol Hepatol 2002;17:253-61.
47. Yamamoto M, Furihata C, Ogiu T, et al. Independent variation in susceptibilities of six different mouse strains to induction of pepsinogen-altered pyloric glands and gastric tumor intestinalization by N-methyl-N-nitrosourea. Cancer Lett 2002; 179:121-32.
48. Tsukamoto T, Yamamoto M, Ogasawara N, et al. β Catenin mutations and nuclear accumulation during progression of rat stomach adenocarcinomas. Cancer Sci 2003;94:1046-51.
49. Shimizu M, Suzui M, Moriwaki H, Mori H, Yoshimi N. No involvement of β-catenin gene mutation in gastric carcinomas induced by N-methyl-N-nitrosourea in male F344 rats. Cancer Lett 2003;195:147-52.
50. Cao X, Tsukamoto T, Nozaki K, et al. 7beta;-Catenin gene alteration in glandular stomach adenocarcinomas in N-methyl-N-nitrosourea- treated and Helicobacter pylori-infected Mongolian gerbils. Cancer Sci 2004;95:487-90.